Table 2.

Patient characteristics

	Overall (N=14)	Dose Level 1 (N=8)	Dose Level 2 (N=6)
Age, median(range)	65 (24,74)	66 (34,72)	63 (24,74)
Gender
Female	7 (50%)	3 (37.5%)	4 (66.7%)
Male	7 (50%)	5 (62.5%)	2 (33.3%)
Race
White	14 (100%)	8 (100%)	6 (100%)
Performance Score
0	6 (42.9%)	3 (37.5%)	3 (50%)
1	8 (57.1%)	5 (62.5%)	3 (50%)
Prior Treatments
Chemotherapy	12 (85.7%)	7 (87.5%)	5 (83.3%)
Radiation Therapy	3 (21.4%)	2 (25%)	1 (16.7%)
Surgery	12 (85.7%)	6 (75%)	6 (100%)
Tumor Site
Kidney	3 (21.4%)	1 (12.5%)	2 (33.3%)
Lung	3 (21.4%)	0 (0%)	3 (50%)
Pancreas	2 (14.3%)	2 (25%)	0 (0%)
Breast	1 (7.1%)	1 (12.5%)	0 (0%)
Adrenal Gland	1 (7.1%)	0 (0%)	1 (16.7%)
Multiple Myeloma	1 (7.1%)	1 (12.5%)	0 (0%)
CLL	1 (7.1%)	1 (12.5%)	0 (0%)
Spindle Cell Tumor	1 (7.1%)	1 (12.5%)	0 (0%)
Melanoma	1 (7.1%)	1 (12.5%)	0 (0%)